Lack of genetic association of promoter and structural variants of mannan-binding lectin (MBL2) gene with susceptibility to generalized vitiligo

British Journal of Dermatology

Volumn 161, Issue 1, 2009, Pages 63-69

  Dwivedi, M ^a   Gupta, K ^b   Gulla, K C ^b   Laddha, N C ^a   Hajela, K ^b   Begum, R ^a  

^a M S UNIVERSITY OF BARODA   (India)

^b DEVI AHILYA UNIVERSITY   (India)

Author keywords

Autoimmunity; Mannan binding lectin (MBL); MBL2gene polymorphisms; Vitiligo

Indexed keywords

MANNAN BINDING LECTIN;

ADULT; ARTICLE; AUTOIMMUNE DISEASE; CASE CONTROL STUDY; CODON; CONTROLLED STUDY; CORRELATION ANALYSIS; EXON; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HETERODUPLEX ANALYSIS; HUMAN; INDIA; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; VITILIGO;

ADULT; CASE-CONTROL STUDIES; CODON; EXONS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HETERODUPLEX ANALYSIS; HUMANS; MALE; MANNOSE-BINDING LECTIN; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; VITILIGO;

EID: 67649908739     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2009.09140.x     Document Type: Article

References (51)

1. Taieb A, Picardo M, VETF members. The definition and assessment of vitiligo: a consensus report of the Vitiligo European Task Force. Pigment Cell Res 2007 20 : 27 35. (Pubitemid 46090162)
2. Handa S, Kaur I. Vitiligo: clinical findings in 1436 patients. J Dermatol 1999 10 : 653 7.
3. Valia AK, Dutta PK, eds. Textbook and Atlas of Dermatology (Indian Association of Dermatologists, Venereologists and Leprologists). Bombay : Bhalani Publishing House, 1996 500 86.
4. Shajil EM, Agrawal D, Vagadia K et al. Vitiligo: clinical profiles in Vadodara, Gujarat. Indian J Dermatol 2006 51 : 100 4.
5. Kemp EH, Waterman EA, Weetman AP. Immunological pathomechanisms in vitiligo. Expert Rev Mol Med 2001 23 : 1.
6. Njoo MD, Westerhof W. Vitiligo: pathogenesis and treatment. Am J Clin Dermatol 2001 2 : 167 81.
7. Nordlund JJ. The epidemiology and genetics of vitiligo. Clin Dermatol 1997 15 : 875 8.
8. Nath SK, Majumder PP, Nordlund JJ. Genetic epidemiology of vitiligo: multilocus recessivity cross-validated. Am J Hum Genet 1994 55 : 981 90.
9. Blomhoff A, Kemp EH, Gawkrodger DJ et al. CTLA4 polymorphisms are associated with vitiligo in patients with concomitant autoimmune diseases. Pigment Cell Res 2005 18 : 55 8.
10. Kemp EH, Ajjan RA, Waterman EA et al. Analysis of a cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphism in patients with vitiligo. Br J Dermatol 1999 140 : 73 8.
11. McCormack WT, Bradley CA, Kristensen DL, She JX. Genetics of vitiligo susceptibility: association studies of immune response genes. Pigment Cell Res 2001 14 : 231.
12. Alkhateeb A, Stetler GL, Old W et al. Mapping of an autoimmunity susceptibility locus (AIS1) to chromosome 1p313-p322. Hum Mol Genet 2001 11 : 661 7.
13. Fain PR, Gowan K, LaBerge GS et al. A genomewide screen for generalized vitiligo: confirmation of AIS1 on chromosome 1p31 and evidence for additional susceptibility loci. Am J Hum Genet 2003 72 : 1560 4.
14. Spritz RA, Gowan K, Bennett DC, Fain PR. Novel vitiligo susceptibility loci on chromosomes 7 (ASI2) and 8 (ASI3), confirmation of SLEV1 on chromosome 17, and their roles in an autoimmune diathesis. Am J Hum Genet 2004 74 : 188 91.
15. Nagamine K, Peterson P, Scott HS et al. Positional cloning of the APECED gene. Nat Genet 1997 17 : 393 8.
16. Jin Y, Mailloux CM, Gowan K et al. NALP1 in vitiligo-associated multiple autoimmune disease. N Engl J Med 2007 356 : 1216 25.
17. Jin Y, Birlea SA, Fain PR, Spritz RA. Genetic variations in NALP1 are associated with generalized vitiligo in a Romanian population. J Invest Dermatol 2007 127 : 2558 62.
18. Laberge GS, Birlea SA, Fain PR, Spritz RA. The PTPN22-1858C>T (R620W) functional polymorphism is associated with generalized vitiligo in the Romanian population. Pigment Cell Melanoma Res 2008 21 : 206 8.
19. LaBerge GS, Bennett DC, Fain PR, Spritz RA. PTPN22 is genetically associated with risk of generalized vitiligo, but CTLA4 is not. J Invest Dermatol 2008 128 : 1757 62.
20. Vang T, Miletic AV, Bottini N, Mustelin T. Protein tyrosine phosphatase PTPN22 in human autoimmunity. Autoimmunity 2007 40 : 453 61.
21. Le Poole IC, Luiten RM. Autoimmune etiology of generalized vitiligo. Curr Dir Autoimmun 2008 10 : 227 43.
22. Fain PR, Babu SR, Bennett DC, Spritz RA. HLA class II haplotype DRB1*04-DQB1*0301 contributes to risk of familial generalized vitiligo and early disease onset. Pigment Cell Res 2006 19 : 51 7.
23. Neth O, Jack DL, Dodds AW et al. Mannose binding lectin binds to a range of clinically relevant microorganisms and promotes complement deposition. Infect Immun 2000 68 : 688 93.
24. Turner MW. The role of mannose-binding lectin in health and disease. Mol Immunol 2003 40 : 423 9.
25. Turner MW, Hamvas RM. Mannose-binding lectin: structure, function, genetics and disease associations. Rev Immunogenet 2000 2 : 305 22.
26. Werth VP, Berlin JA, Callen JP et al. Mannose binding lectin (MBL) polymorphisms associated with low MBL production in patients with dermatomyositis. J Invest Dermatol 2002 119 : 1394 9.
27. Jack DL, Read RC, Tenner AJ et al. Mannose-binding lectin regulates the inflammatory response of human professional phagocytes to Neisseria meningitidis serogroup B. J Infect Dis 2001 184 : 1152 62.
28. Sumiya M, Super M, Tabona P et al. Molecular basis of opsonic defect in immunodeficient children. Lancet 1991 337 : 1569 70.
29. Lipscombe RJ, Sumiya M, Hill AV et al. High frequencies in African and non-African populations of independent mutations in the mannose binding protein gene. Hum Mol Genet 1992 1 : 709 15.
30. Hansen S, Holmskov U. Structural aspects of collectins and receptors for collectins. Immunobiology 1998 199 : 165 89.
31. Garred P, Larsen F, Madsen HO, Koch C. Mannose-binding lectin deficiency: revisited. Mol Immunol 2003 40 : 73 84.
32. Thiel S. Complement activating soluble pattern recognition molecules with collagen-like regions, mannan-binding lectin, ficolins and associated proteins. Mol Immunol 2007 44 : 3875 88.
33. Madsen HO, Garred P, Thiel S et al. Interplay between promoter and structural gene variants control basal serum level of mannan-binding protein. J Immunol 1995 155 : 3013 20.
34. Onay H, Pehlivan M, Alper S et al. Might there be a link between mannose binding lectin and vitiligo? Eur J Dermatol 2007 17 : 146 8.
35. Jack D, Bidwell J, Turner M, Wood N. Simultaneous genotyping for all three known structural mutations in the human mannose-binding lectin gene. Hum Mutat 1997 9 : 41 6.
36. Ochi Y, DeGroot LJ. Vitiligo in Graves' disease. Ann Intern Med 1969 71 : 935 40.
37. Laddha NC, Dwivedi M, Shajil EM et al. Association of PTPN22 1858C/T polymorphism with vitiligo susceptibility in Gujarat population. J Dermatol Sci 2008 49 : 260 2.
38. Dwivedi M, Laddha NC, Shajil EM et al. The ACE gene I/D polymorphism is not associated with generalized vitiligo susceptibility in Gujarat population. Pigment Cell Melanoma Res 2008 21 : 407 8.
39. Wallis R. Dominant effects of mutations in the collagenous domain of mannose-binding protein. J Immunol 2002 168 : 4553 8.
40. Yokota Y, Arai T, Kawasaki T. Oligomeric structures required for complement activation of serum mannan-binding proteins. J Biochem 1995 117 : 414 19.
41. Schallreuter KU, Pittelkow MR, Swanson NN. Defective calcium transport in vitiliginous melanocytes. Arch Dermatol Res 1996 228 : 11 13. (Pubitemid 26009219)
42. Schallreuter KU, Pittelkow MR. Defective calcium uptake in keratinocyte cell culture from vitiliginous skin. Arch Dermatol Res 1988 280 : 137 9.
43. Davies EJ, Snowden N, Hillarby MC et al. Mannose-binding protein gene polymorphism in systemic lupus erythematosus. Arthritis Rheum 1995 38 : 110 14.
44. Ip WK, Chan SY, Lau CS, Lau YL. Association of systemic lupus erythematosus with promoter polymorphisms of the mannose-binding lectin gene. Arthritis Rheum 1998 41 : 1663 8.
45. Senaldi G, Davies ET, Peakman M et al. Frequency of mannose-binding protein deficiency in patients with systemic lupus erythematosus. Arthritis Rheum 1995 38 : 1713 14.
46. Wang ZY, Morinobu A, Kanagawa S, Kumagai S. Polymorphisms of the mannose binding lectin gene in patients with Sjögren's syndrome. Ann Rheum Dis 2001 60 : 483 6.
47. Graudal NA, Homann C, Madsen HO et al. Mannan binding lectin in rheumatoid arthritis. A longitudinal study. J Rheumatol 1998 25 : 629 35.
48. Graudal NA, Madsen HO, Tarp U et al. The association of variant mannose-binding lectin genotypes with radiographic outcome in rheumatoid arthritis. Arthritis Rheum 2000 43 : 515 21.
49. Horiuchi T, Tsukamoto H, Morita C et al. Mannose binding lectin (MBL) gene mutation is not a risk factor for systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) in Japanese. Genes Immun 2000 1 : 464 6.
50. Kilpatrick DC. Mannan binding protein in sera positive for rheumatoid factor. Br J Rheumatol 1997 36 : 207 9.
51. Rector A, Lemey P, Laffut W et al. Mannan-binding lectin (MBL) gene polymorphisms in ulcerative colitis and Crohn's disease. Genes Immun 2001 2 : 323 8.